Clinical trial
Digital Phenotyping (Physical Activity, Heart Rate, Sleep) in Young Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
NCT05011721 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Digital Phenotyping (Physical Activity, Heart Rate, Sleep) in Young Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
- Lead sponsor
- Institut Curie
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 20, 2021
- Completion date
- March 3, 2025
- Enrollment
- 300 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer